Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Net Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Net Margin data on record, last reported at 5.62% in Q2 2025.

  • For Q2 2025, Net Margin rose 1308.0% year-over-year to 5.62%; the TTM value through May 2025 reached 34.42%, down 4252.0%, while the annual FY2025 figure was 34.42%, 4379.0% down from the prior year.
  • Net Margin reached 5.62% in Q2 2025 per LFCR's latest filing, up from 49.44% in the prior quarter.
  • Across five years, Net Margin topped out at 43.78% in Q1 2024 and bottomed at 94.88% in Q1 2023.
  • Average Net Margin over 5 years is 18.12%, with a median of 11.31% recorded in 2022.
  • Peak YoY movement for Net Margin: soared 13866bps in 2024, then crashed -9322bps in 2025.
  • A 5-year view of Net Margin shows it stood at 4.97% in 2021, then tumbled by -432bps to 16.49% in 2022, then soared by 100bps to 0.08% in 2023, then tumbled by -33474bps to 26.73% in 2024, then soared by 79bps to 5.62% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 5.62% in Q2 2025, 49.44% in Q1 2025, and 26.73% in Q4 2024.